<DOC>
	<DOCNO>NCT02179931</DOCNO>
	<brief_summary>To establish bioequivalence flupentixol/melitracen new film-coated tablet formulation 0.5 mg flupentixol/10 mg melitracen market coated tablet formulation 0.5 mg flupentixol/10 mg melitracen ( Deanxit® ) , administer single dos .</brief_summary>
	<brief_title>Bioequivalence Study Healthy Men Women Compare Two Pharmaceutical Formulations Flupentixol/Melitracen ( Deanxit® )</brief_title>
	<detailed_description />
	<mesh_term>Flupenthixol</mesh_term>
	<mesh_term>Flupenthixol decanoate</mesh_term>
	<criteria>Healthy men woman ≥18 ≤55 year age body mass index ( BMI ) &gt; 18.5 &lt; 30 kg/m2 . Women nonpregnant nonlactating . Other protocoldefined inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>